WINKAST-SF-500 LIFECAPS
PULMOLIFE
Upcoming

WINKAST-SF-500 LIFECAPS

MRP: 2

Packaging: 1X30caps

Pack Type: capsule

Composition:

Salmeterol 50mcg + Fluticasone 500mcg

Indication:

Used for long-term management of asthma and COPD to reduce airway inflammation and improve breathing.

Description:

Salmeterol 50 mcg + Fluticasone Propionate 500 mcg is a fixed-dose combination inhaler used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).

  • Salmeterol is a long-acting beta-2 agonist (LABA) that relaxes bronchial smooth muscles, improving airflow.

  • Fluticasone is an inhaled corticosteroid (ICS) that reduces airway inflammation and prevents asthma symptoms.

This combination provides prolonged bronchodilation and anti-inflammatory control, helping reduce the frequency and severity of asthma attacks and COPD exacerbations.

Tags:

Respiratory Care
Asthma Inhalers
COPD Treatment
Bronchodilators
Inhaled Corticosteroids
  • Provides 12-hour bronchodilation for asthma/COPD
  • Reduces airway inflammation and hyperresponsiveness
  • Improves lung function and exercise tolerance
  • Decreases frequency of asthma attacks or flare-ups
  • Once or twice daily dosing improves compliance

Usage Information

Dosage

Adults and adolescents (>12 years): 1 inhalation twice daily (usually morning and evening) Inhalation technique is critical: Use a spacer if needed, and rinse mouth after each use to avoid oral thrush.

Side Effects

Hoarseness or throat irritation Oral candidiasis (thrush) Headache, cough Rare: Palpitations, tremors, muscle cramps Long-term ICS use: Potential risk of adrenal suppression or bone loss (with prolonged high doses)

Contraindications

Known allergy to salmeterol or fluticasone Acute asthma attack or COPD exacerbation Children under 12 years (500 mcg strength may be too high) Not to be used as monotherapy in asthma (LABA alone increases risk of asthma-related death)